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androgenetic alopecia who also present with particularly 
elevated dihydrotestosterone–testosterone ratios. The bald-
ness theory should be included as a secondary hypothesis in 
large epidemiological studies of CAD.
These predominantly inconclusive studies from the pre-
vious century are counterbalanced by several other positive 
studies performed in the current century. In 2000, Lotufo et 
al. [5] showed, in a retrospective cohort study among 22,071 
US male physicians aged 40–84 years enrolled in the Physi-
cians’ Health Study, that vertex pattern baldness appeared to 
be a marker for increased risk of coronary events, especially 
among men with hypertension or high cholesterol levels. In 
2001, Matilainen et al. [6] tested if the early onset of alope-
cia was a risk factor for early CAD in 85 men requiring cor-
onary revascularization, and if the early onset of androgenic 
alopecia differed in this respect from the late onset of male 
baldness. The adjusted odds ratio for the coronary revascu-
larization procedure at any age was 1.84 in the subgroup of 
the men with early androgenetic alopecia compared to those 
with late androgenic alopecia or normal hair status. These 
results support the hypothesis that the early onset of andro-
genic alopecia is a risk factor for an early onset of severe 
CAD.
Interestingly, in 2005 Mansouri et al. [7] found an asso-
ciation between androgenetic alopecia and CAD in women. 
The study was carried out in 106 women under the age 
55, who underwent coronary arteriography to diagnose 
CAD. The correlation of androgenetic alopecia and CAD, 
androgenetic alopecia and a previous history of myocardial 
infarction, and greying of hair and CAD were statistically 
significant after adjustment of data for differences in age. 
These data support the hypothesis that female androgenetic 
alopecia, like male pattern baldness, is associated with CAD 
in women under the age 55.
In the literature, there have been conflicting reports on an 
association between male baldness (androgenetic alopecia) 
and the incidence of coronary artery disease (CAD).
In 1979, Cooke [1] studied the prevalence of male pattern 
alopecia, CAD, hypertension, and smoking habits in 478 
male Caucasian hospital inpatients over the age of 20 years. 
No association was shown between CAD and either male 
pattern alopecia, premature male pattern alopecia, or male 
pattern alopecia with a positive family history of CAD. In 
1990, Herrera et al. [2] identified eight articles containing 
data on both baldness and CAD. Three of these articles 
were case-control studies that showed a positive relation-
ship between baldness and CAD, when controlling for CAD 
risk factors. Three other case-control studies showed no 
such relationship, but these did not control for CAD risk 
factors. The results of two cohort studies were inconclu-
sive. Insufficient data were available from these studies to 
analyze possible relationships between baldness and CAD 
risk factors themselves. Overall, the data suggested that a 
small risk of CAD due to baldness might exist, but this risk 
is much smaller than that of well-known CAD risk factors 
such as smoking and hypertension [3].
In 2001, Rebora et al. [4] performed a review of 24 
articles in the literature from 1954 to 1999 as provided by 
MEDLINE. Baldness did not coincide with androgenetic 
alopecia in several of the articles examined, which makes 
it difficult to settle the issue. Subjects who develop bald-
ness before their 30s may have a higher risk for CAD than 
other men, and there may be individuals with early-onset 
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Recently, two studies from the same group showed that 
early onset androgenetic alopecia in males was indepen-
dently associated with CAD [8, 9]. In 2013, Sharma et al. 
[8] performed a comparative study of CAD risk factors in 
100 males with androgenetic alopecia grade II between the 
age of 25 and 40 years with an equal number of age- and 
sex-matched controls. Patients with androgenetic alopecia 
appeared to be at an increased risk of developing CAD; 
therefore, clinical evaluation of cases with androgenetic 
alopecia grade II and beyond may be of help in preventing 
CAD in future. Finally, in 2014, the same group investigated 
the prevalence of androgenetic alopecia in 424 young (< 45 
years) Asian Indian Gujarati male patients [9]. A statisti-
cally significant association was found between high-grade 
baldness (Grades IV-VII) and CAD in young men (p < 0.05). 
This study implies that early-onset androgenetic alopecia in 
males is independently associated with CAD, though the 
mechanisms need to be investigated.
In the current issue of the Netherlands Heart Journal, Sari 
et al. [10] investigated the association between male pattern 
baldness and angiographic severity of CAD and collateral 
development. Coronary arteriograms, CAD risk factors, 
lipid parameters, and presence and severity of baldness were 
prospectively evaluated in 511 male patients. Baldness was 
classified into five groups. Severity of CAD was evaluated 
with the Gensini score and collateral development with the 
Rentrop score, being important measures of presence and 
severity of CAD. Bald patients had higher Gensini scores 
when compared with their nonbald counterparts. In univari-
ate analysis, age over 60 years, body mass index more than 
30, smoking, and baldness were predictors of high Gensini 
scores. However, in multivariate analysis only age over 60 
years, body mass index more than 30, and smoking were 
independent predictors of high Gensini scores. No differ-
ences were observed in presence and severity of baldness in 
subjects with and without adequate collateral development. 
Consequently, the authors did not observe a significant rela-
tion between presence, severity, and age of the occurrence 
of male pattern baldness and severity of CAD.
The present study by Sari et al. [10] provides impor-
tant data as it contradicts recent studies. The study clearly 
argues against a significant relationship between androge-
netic alopecia and CAD; moreover, Sari et al. are the first 
to investigate the association between male pattern baldness 
and angiographic CAD severity and collateral develop-
ment. In addition, the study provided interesting data such 
as presence, severity and age of occurrence of male pattern 
baldness, associated hypertension, and hyperlipidaemia. 
Of course, as also recognized by the authors, the study has 
the limitation of having a cross-sectional design. Prospec-
tive studies would provide more valuable information to 
draw conclusions about the occurrence of clinical coronary 
events in relation to androgenetic alopecia.
Altogether, it goes too far to say that bald is beautiful, but 
for many men it might be reassuring that male baldness is 
not significantly associated with CAD.
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